First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC) Meeting Abstract
| Authors: | Bajorin, D. F.; Witjes, J. A.; Gschwend, J.; Schenker, M.; Valderrama, B. P.; Tomita, Y.; Bamias, A.; Lebret, T.; Shariat, S.; Park, S. H.; Ye, D.; Agerbaek, M.; Collette, S.; Unsal-Kacmaz, K.; Zardavas, D.; Koon, H. B.; Galsky, M. D. |
| Abstract Title: | First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC) |
| Meeting Title: | 2021 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2021 Feb 11-13 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-02-20 |
| Language: | English |
| ACCESSION: | WOS:000636801500394 |
| DOI: | 10.1200/JCO.2021.39.6_suppl.391 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 391 -- Source: Wos |
